Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

The construction and characterization of the bi-directional promoter between pp38 gene and 1.8-kb mRNA transcripts of Marek's disease viruses

Authors: Ruiai Chen, Jiabo Ding, Bin Wang

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Marek's disease virus (MDV) has a bi-directional promoter between pp38 gene and 1.8-kb mRNA transcripts. By sequencing for the promoters from 8 different strains (CVI988, 814, GA, JM, Md5, G2, RB1B and 648A), it is found, comparing with the other 7 MDV strains, CVI988 has a 5-bp (from -628 to -632) deletion in this region, which caused a Sp1 site destroyed. In order to analysis the activity of the promoter, the complete bi-directional promoters from GA and CVI988 were, respectively, cloned into pCAT-Basic vector in both directions for the recombinants pPGA(pp38)-CAT, pPGA(1.8 kb)-CAT, pPCVI(pp38)-CAT and pPCVI(1.8 kb)-CAT. The complete promoter of GA was divided into two single-direction promoters from the replication of MDV genomic DNA, and cloned into pCAT-Basic for pdPGA(pp38)-CAT and pdPGA(1.8 kb)-CAT as well. The above 6 recombinants were then transfected into chicken embryo fibroblasts (CEFs) infected with MDV, and the activity of chloramphenicol acetyltransferase (CAT) was measured from the lysed CEFs 48 h post transfection.

Results

The results showed the activity of the divided promoters was decreased on both directions. In 1.8-kb mRNA direction, it is nearly down to 2.4% (19/781) of the whole promoter, while it keeps 65% (34/52) activity in pp38 direction. The deletion of Sp1 site in CVI988 causes the 20% activity decreased, and has little influence in pp38 direction.

Conclusion

The present study confirmed their result, and the promoter for the 1.8-kb mRNA transcripts is a much stronger promoter than that in the orientation for pp38.
Appendix
Available only for authorised users
Literature
1.
go back to reference Addinger HK, Calnek BW: Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J Natl Cancer Inst 1973, 50: 1287-1298.PubMed Addinger HK, Calnek BW: Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J Natl Cancer Inst 1973, 50: 1287-1298.PubMed
2.
go back to reference Bradley G, Hayashi M, Lancz G, Tanaka A, Nonoyama M: Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol 1989, 63: 2534-2542.PubMedCentralPubMed Bradley G, Hayashi M, Lancz G, Tanaka A, Nonoyama M: Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol 1989, 63: 2534-2542.PubMedCentralPubMed
3.
go back to reference Bradley G, Lancz G, Tanaka A, Nonoyama M: Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. J Virol 1989, 63: 4129-4135.PubMedCentralPubMed Bradley G, Lancz G, Tanaka A, Nonoyama M: Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. J Virol 1989, 63: 4129-4135.PubMedCentralPubMed
4.
go back to reference Cui ZZ, Lee LF, Liu JL, Kung HJ: Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol 1991, 65: 6509-6515.PubMedCentralPubMed Cui ZZ, Lee LF, Liu JL, Kung HJ: Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol 1991, 65: 6509-6515.PubMedCentralPubMed
5.
go back to reference Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK: Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci USA 1992, 89: 4042-4046. 10.1073/pnas.89.9.4042PubMedCentralCrossRefPubMed Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK: Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci USA 1992, 89: 4042-4046. 10.1073/pnas.89.9.4042PubMedCentralCrossRefPubMed
6.
go back to reference Xie Q, Anderson AS, Morgan RW: Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J Virol 1996, 70: 1125-1131.PubMedCentralPubMed Xie Q, Anderson AS, Morgan RW: Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J Virol 1996, 70: 1125-1131.PubMedCentralPubMed
7.
go back to reference Ikuta K, Nakajima K, Naito M, Ann SH, Ueda S, Kato S, Hirai K: Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides. Int J Cancer 1985, 35: 257-264. 10.1002/ijc.2910350219CrossRefPubMed Ikuta K, Nakajima K, Naito M, Ann SH, Ueda S, Kato S, Hirai K: Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides. Int J Cancer 1985, 35: 257-264. 10.1002/ijc.2910350219CrossRefPubMed
8.
go back to reference Nakajima K, Ikuta K, Naito M, Ueda S, Kato S, Hirai K: Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells. J Gen Virol 1987,68(Pt 5):1379-1389. 10.1099/0022-1317-68-5-1379CrossRefPubMed Nakajima K, Ikuta K, Naito M, Ueda S, Kato S, Hirai K: Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells. J Gen Virol 1987,68(Pt 5):1379-1389. 10.1099/0022-1317-68-5-1379CrossRefPubMed
9.
go back to reference Maotani K, Kanamori A, Ikuta K, Ueda S, Kato S, Hirai K: Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J Virol 1986, 58: 657-660.PubMedCentralPubMed Maotani K, Kanamori A, Ikuta K, Ueda S, Kato S, Hirai K: Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J Virol 1986, 58: 657-660.PubMedCentralPubMed
10.
go back to reference Peng Q, Zeng M, Bhuiyan ZA, Ubukata E, Tanaka A, Nonoyama M, Shirazi Y: Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 1995, 213: 590-599. 10.1006/viro.1995.0031CrossRefPubMed Peng Q, Zeng M, Bhuiyan ZA, Ubukata E, Tanaka A, Nonoyama M, Shirazi Y: Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 1995, 213: 590-599. 10.1006/viro.1995.0031CrossRefPubMed
11.
go back to reference Witter RL, Silva RF, Lee LF: New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics. Avian Dis 1987, 31: 829-840. 10.2307/1591039CrossRefPubMed Witter RL, Silva RF, Lee LF: New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics. Avian Dis 1987, 31: 829-840. 10.2307/1591039CrossRefPubMed
12.
go back to reference Zhu GS, Ojima T, Hironaka T, Ihara T, Mizukoshi N, Kato A, Ueda S, Hirai K: Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification. Avian Dis 1992, 36: 637-645. 10.2307/1591759CrossRefPubMed Zhu GS, Ojima T, Hironaka T, Ihara T, Mizukoshi N, Kato A, Ueda S, Hirai K: Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification. Avian Dis 1992, 36: 637-645. 10.2307/1591759CrossRefPubMed
13.
go back to reference Smith GD, Zelnik V, Ross LJ: Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 1995, 207: 205-216. 10.1006/viro.1995.1067CrossRefPubMed Smith GD, Zelnik V, Ross LJ: Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 1995, 207: 205-216. 10.1006/viro.1995.1067CrossRefPubMed
14.
go back to reference Camp HS, Coussens PM, Silva RF: Cloning, sequencing, and functional analysis of a Marek's disease virus origin of DNA replication. J Virol 1991, 65: 6320-6324.PubMedCentralPubMed Camp HS, Coussens PM, Silva RF: Cloning, sequencing, and functional analysis of a Marek's disease virus origin of DNA replication. J Virol 1991, 65: 6320-6324.PubMedCentralPubMed
15.
go back to reference Katsumata A, Iwata A, Ueda S: Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1. J Gen Virol 1998,79(Pt 12):3015-3018.CrossRefPubMed Katsumata A, Iwata A, Ueda S: Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1. J Gen Virol 1998,79(Pt 12):3015-3018.CrossRefPubMed
16.
go back to reference Shigekane H, Kawaguchi Y, Shirakata M, Sakaguchi M, Hirai K: The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers. Arch Virol 1999, 144: 1893-1907. 10.1007/s007050050713CrossRefPubMed Shigekane H, Kawaguchi Y, Shirakata M, Sakaguchi M, Hirai K: The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers. Arch Virol 1999, 144: 1893-1907. 10.1007/s007050050713CrossRefPubMed
17.
go back to reference Ding J, Cui Z, Lee LF, Cui X, Reddy SM: The role of pp38 in regulation of Marek's disease virus bi-directional promoter between pp38 and 1.8-kb mRNA. Virus Genes 2006, 32: 193-201. 10.1007/s11262-005-6876-2CrossRefPubMed Ding J, Cui Z, Lee LF, Cui X, Reddy SM: The role of pp38 in regulation of Marek's disease virus bi-directional promoter between pp38 and 1.8-kb mRNA. Virus Genes 2006, 32: 193-201. 10.1007/s11262-005-6876-2CrossRefPubMed
18.
go back to reference Ding JB, Cui ZZ, Jiang SJ: The enhancement effect of pp38 gene product on the activity of its upstream bi-directional promoter in Marek's disease virus. Sci China C Life Sci 2006, 49: 53-62. 10.1007/s11427-004-0119-yCrossRef Ding JB, Cui ZZ, Jiang SJ: The enhancement effect of pp38 gene product on the activity of its upstream bi-directional promoter in Marek's disease virus. Sci China C Life Sci 2006, 49: 53-62. 10.1007/s11427-004-0119-yCrossRef
19.
go back to reference Ding J, Cui Z, Lee LF: Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts. Virus Genes 2007, 35: 643-650. 10.1007/s11262-007-0129-5CrossRefPubMed Ding J, Cui Z, Lee LF: Marek's disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts. Virus Genes 2007, 35: 643-650. 10.1007/s11262-007-0129-5CrossRefPubMed
20.
go back to reference Ding J, Cui Z, Jiang S, Li Y: Study on the structure of heteropolymer pp38/pp24 and its enhancement on the bi-directional promoter upstream of pp38 gene in Marek's disease virus. Sci China C Life Sci 2008, 51: 821-826. 10.1007/s11427-008-0099-4CrossRefPubMed Ding J, Cui Z, Jiang S, Li Y: Study on the structure of heteropolymer pp38/pp24 and its enhancement on the bi-directional promoter upstream of pp38 gene in Marek's disease virus. Sci China C Life Sci 2008, 51: 821-826. 10.1007/s11427-008-0099-4CrossRefPubMed
21.
go back to reference Reddy SM, Lupiani B, Gimeno IM, Silva RF, Lee LF, Witter RL: Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci USA 2002, 99: 7054-7059. 10.1073/pnas.092152699PubMedCentralCrossRefPubMed Reddy SM, Lupiani B, Gimeno IM, Silva RF, Lee LF, Witter RL: Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci USA 2002, 99: 7054-7059. 10.1073/pnas.092152699PubMedCentralCrossRefPubMed
22.
go back to reference Eidson CS, Schmittle SC: Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens. Avian Dis 1968, 12: 467-476. 10.2307/1588162CrossRefPubMed Eidson CS, Schmittle SC: Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens. Avian Dis 1968, 12: 467-476. 10.2307/1588162CrossRefPubMed
23.
go back to reference Schat KA, Calnek BW, Fabricant J, Abplanalp H: Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance. Poult Sci 1981, 60: 2559-2566.CrossRefPubMed Schat KA, Calnek BW, Fabricant J, Abplanalp H: Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance. Poult Sci 1981, 60: 2559-2566.CrossRefPubMed
24.
go back to reference Witter RL: Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathol 1982, 11: 49-62. 10.1080/03079458208436081CrossRefPubMed Witter RL: Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathol 1982, 11: 49-62. 10.1080/03079458208436081CrossRefPubMed
25.
go back to reference Cui Z, Wei P, Ding J: Molecular comparisons of Marek's disease virus strains of different pathotypes for their gI, gE, pp38 and meq genes. J Shandong Agric Univ 2004.,35(1-5): Cui Z, Wei P, Ding J: Molecular comparisons of Marek's disease virus strains of different pathotypes for their gI, gE, pp38 and meq genes. J Shandong Agric Univ 2004.,35(1-5):
26.
go back to reference Witter RL, Gimeno IM, Reed WM, Bacon LD: An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus. Avian Dis 1999, 43: 704-720. 10.2307/1592740CrossRefPubMed Witter RL, Gimeno IM, Reed WM, Bacon LD: An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus. Avian Dis 1999, 43: 704-720. 10.2307/1592740CrossRefPubMed
27.
go back to reference Rispens BH, van Vloten H, Mastenbroek N, Maas HJ, Schat KA: Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis 1972, 16: 108-125. 10.2307/1588905CrossRefPubMed Rispens BH, van Vloten H, Mastenbroek N, Maas HJ, Schat KA: Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis 1972, 16: 108-125. 10.2307/1588905CrossRefPubMed
28.
go back to reference Tong GZ, Lin YH, Xun YW: Study on the immunity of Marek's disease: the cultivation and immunity assay for MDV vaccine strain. Chinese J Anim Poultry Infect Dis 1984, 15: 107-113. Tong GZ, Lin YH, Xun YW: Study on the immunity of Marek's disease: the cultivation and immunity assay for MDV vaccine strain. Chinese J Anim Poultry Infect Dis 1984, 15: 107-113.
Metadata
Title
The construction and characterization of the bi-directional promoter between pp38 gene and 1.8-kb mRNA transcripts of Marek's disease viruses
Authors
Ruiai Chen
Jiabo Ding
Bin Wang
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-212

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine